Cutaneous larva migrans (CLM) is caused by soil-dwelling hookworm larvae penetrating the skin, especially on the feet. It results in a hypersensitivity response after repeated exposure. The larvae secrete enzymes that help them invade and migrate under the skin. Clinically, CLM presents as intensely pruritic, serpiginous red-brown tracks up to several mm per day. The lower extremities are most commonly affected. Diagnosis is based on clinical features alone and treatment involves application of thiabendazole paste or oral anthelmintics like albendazole.
Cutaneous larva migrans (CLM) is caused by soil-dwelling hookworm larvae penetrating the skin, especially on the feet. It results in a hypersensitivity response after repeated exposure. The larvae secrete enzymes that help them invade and migrate under the skin. Clinically, CLM presents as intensely pruritic, serpiginous red-brown tracks up to several mm per day. The lower extremities are most commonly affected. Diagnosis is based on clinical features alone and treatment involves application of thiabendazole paste or oral anthelmintics like albendazole.
Cutaneous larva migrans (CLM) is caused by soil-dwelling hookworm larvae penetrating the skin, especially on the feet. It results in a hypersensitivity response after repeated exposure. The larvae secrete enzymes that help them invade and migrate under the skin. Clinically, CLM presents as intensely pruritic, serpiginous red-brown tracks up to several mm per day. The lower extremities are most commonly affected. Diagnosis is based on clinical features alone and treatment involves application of thiabendazole paste or oral anthelmintics like albendazole.
Dewi M.Darlan Parasitology Department Medical Faculty of USU Cutaneous larva migrans (CLM) Due to: Ancylostoma ceylanicum, A.caninum Strongyloides stercoralis
Dewi M.Darlan 1/24/2010 2
Cutaneous larva migrans (CLM) Pathogenese This condition is caused by contact with soil containing infective larvae (filariform larvae) that are capable of penetrating the skin. This can’t occur after first exposure but follows re- infection only after several weeks, this suggests that the disease is due to hypersensitivity to larval secretions (Provic and Croese, 1996) The larva produces a number of enzymes which may assist in dermal invasion; such as metaloprotease, minor protease and hyluronidase (Hotez, Hawdon and Capello, 1995)
Dewi M.Darlan 1/24/2010 3
Cutaneous larva migrans (CLM) Clinical features
The lower extremities are more often affected
with eruption on the feet, making up almost ⅔ of all cases. A pruritic erythematous papule develops initially at the site of each larvae entry. After 2-3 days, severely pruritic, serpiginous, reddish-brown lesions appear Larvae migrate at a rate of several mm/ day Lesions are intensely itchy, red, and oedematous and show a worm-like migratory pathway under the skin Dewi M.Darlan 1/24/2010 4 Cutaneous larva migrans (CLM) Clinical features
Lesions may also become vesiculated,
encrusted, or secondarily infected. The larvae eventually die and become absorbed without treatment. The cutaneous symptoms typically last For days to months. Only 29% of patients had lesions that persisted for 1 month, but in occasional patients had lesions in follicles and cause disease for as long as 2 years. Dewi M.Darlan 1/24/2010 5 Cutaneous larva migrans (CLM) Diagnosis The diagnosis of CLM is made on the basis of the characteristic clinical features The laboratory has no role to play in diagnosis Eosinophilia is only a feature of minority of cases. Titer IgE is usually normal
Dewi M.Darlan 1/24/2010 6
Cutaneous larva migrans (CLM) Treatment CLM is readily treated by application of 15% thiabendazole paste for 5 days. In severe cases, systemic treatment with albendazole or ivermectin may also be used (Caumes Caumes et al.,1993 al.,1993) Biopsy, surgical excision or liquid nitrogen is contraindicated (Stephen Stephen H.Gillespie H.Gillespie,, in Principle and practice of clinical parasitology,2001) parasitology,2001